Status:
TERMINATED
Thrombolysis in Ischemic Spinal Cord Stroke
Lead Sponsor:
Rabin Medical Center
Conditions:
Motor Weakness in Two or Four Limbs
Damage in the Anterior Spinal Artery (ASA)
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
Ischemic stroke of the spinal cord is a rare disease accounting for about 1% of all ischemic events in the central nervous system (CNS). In most cases the consequences are catastrophic, with a high ra...
Eligibility Criteria
Inclusion
- Patients with vascular risk factors
- Patients with sudden weakness of the lower or upper limbs together with bowel disorder.
- Window treatment - not over 6 hours since the start of the event till the start of the treatment.
- Patient without dissection of the aorta in the abdomen.
- Patient without contraindication to IVtPA.
- Patient with no etiology found after clarification.
Exclusion
- 1\. Refusal to sign an ICF. 2. Reason for weakness is known. 3. Patient with contraindication IVtPA.
- \-
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2019
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02242084
Start Date
April 1 2016
End Date
March 26 2019
Last Update
March 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petach Tiqva, Central District, Israel, 49100